» Articles » PMID: 19854937

Enhanced Gene Repair Mediated by Methyl-CpG-modified Single-stranded Oligonucleotides

Overview
Specialty Biochemistry
Date 2009 Oct 27
PMID 19854937
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Gene editing mediated by oligonucleotides has been shown to induce stable single base alterations in genomic DNA in both prokaryotic and eukaryotic organisms. However, the low frequencies of gene repair have limited its applicability for both basic manipulation of genomic sequences and for the development of therapeutic approaches for genetic disorders. Here, we show that single-stranded oligodeoxynucleotides (ssODNs) containing a methyl-CpG modification and capable of binding to the methyl-CpG binding domain protein 4 (MBD4) are able to induce >10-fold higher levels of gene correction than ssODNs lacking the specific modification. Correction was stably inherited through cell division and was confirmed at the protein, transcript and genomic levels. Downregulation of MBD4 expression using RNAi prevented the enhancement of gene correction efficacy obtained using the methyl-CpG-modified ssODN, demonstrating the specificity of the repair mechanism being recruited. Our data demonstrate that efficient manipulation of genomic targets can be achieved and controlled by the type of ssODN used and by modulation of the repair mechanism involved in the correction process. This new generation of ssODNs represents an important technological advance that is likely to have an impact on multiple applications, especially for gene therapy where permanent correction of the genetic defect has clear advantages over viral and other nonviral approaches currently being tested.

Citing Articles

Modification of improved-genome editing via oviductal nucleic acids delivery (i-GONAD)-mediated knock-in in rats.

Aoshima T, Kobayashi Y, Takagi H, Iijima K, Sato M, Takabayashi S BMC Biotechnol. 2021; 21(1):63.

PMID: 34724929 PMC: 8561937. DOI: 10.1186/s12896-021-00723-5.


High Homology-Directed Repair Using Mitosis Phase and Nucleus Localizing Signal.

Han J, Chang Y, Song D, Choi B, Koo O, Yi S Int J Mol Sci. 2020; 21(11).

PMID: 32466470 PMC: 7312558. DOI: 10.3390/ijms21113747.


Urine mRNA to identify a novel pseudoexon causing dystrophinopathy.

Antoury L, Hu N, Darras B, Wheeler T Ann Clin Transl Neurol. 2019; 6(6):1106-1112.

PMID: 31211175 PMC: 6562067. DOI: 10.1002/acn3.777.


A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells.

Rivera-Torres N, Kmiec E J Vis Exp. 2017; (126).

PMID: 28872131 PMC: 5614406. DOI: 10.3791/56195.


To cleave or not to cleave: therapeutic gene editing with and without programmable nucleases.

Woolf T, Gurumurthy C, Boyce F, Kmiec E Nat Rev Drug Discov. 2017; 16(4):296.

PMID: 28303022 DOI: 10.1038/nrd.2017.42.


References
1.
Chan P, Lin M, Faruqi A, Powell J, Seidman M, Glazer P . Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J Biol Chem. 1999; 274(17):11541-8. DOI: 10.1074/jbc.274.17.11541. View

2.
Flagler K, Alexeev V, Pierce E, Igoucheva O . Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells. Gene Ther. 2008; 15(14):1035-48. DOI: 10.1038/gt.2008.31. View

3.
Lindahl T, Wood R . Quality control by DNA repair. Science. 1999; 286(5446):1897-905. DOI: 10.1126/science.286.5446.1897. View

4.
Sangiuolo F, Bruscia E, Serafino A, Nardone A, Bonifazi E, Lais M . In vitro correction of cystic fibrosis epithelial cell lines by small fragment homologous replacement (SFHR) technique. BMC Med Genet. 2002; 3:8. PMC: 130050. DOI: 10.1186/1471-2350-3-8. View

5.
Millar C, Guy J, Sansom O, Selfridge J, MacDougall E, Hendrich B . Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science. 2002; 297(5580):403-5. DOI: 10.1126/science.1073354. View